Log In
Print
BCIQ
Print
Print this Print this
 

AMG 416, ONO-5163 (formerly KAI-4169, Velcalcetide)

  Manage Alerts
Collapse Summary General Information
Company Amgen Inc.
DescriptionPeptide calcimimetic that acts on the parathyroid gland to reduce production of parathyroid hormone (PTH)
Molecular Target Calcium sensing receptor (CaSR)
Mechanism of ActionCalcium-sensing receptor (CaSR) agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationThyroid disease
Indication DetailsTreat secondary hyperparathyroidism (SHPT); Treat secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease (CKD) receiving hemodialysis
Regulatory Designation

Partner

Ono Pharmaceutical Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today